Iovance Biotherapeutics, Inc.
Solid-tumor cell-therapy company commercializing lifileucel and expanding TIL therapy across melanoma, lung and other cancers.
Oncology / solid tumors · Autologous tumor-infiltrating lymphocyte (TIL) cell therapy · Commercial + Phase 3